Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini L Kulasingam

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
JAMA|October 9, 2002
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referralShalini L Kulasingam, James P Hughes, Nancy B Kiviat, et al.
American Journal of Obstetrics and Gynecology|March 4, 2008
Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United StatesJanet G Baseman, Shalini L Kulasingam, Tiffany G Harris, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samplesAkhila Balasubramanian, Shalini L Kulasingam, Atar Baer, et al.
Obstetrics and Gynecology|February 2, 2006
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap testsShalini L Kulasingam, Evan R Myers, Herschel W Lawson, et al.
American Journal of Obstetrics and Gynecology|July 4, 2014
Adherence to the 2012 national cervical cancer screening guidelines: a pilot studyDeanna G K Teoh, Amity E Marriott, Rachel Isaksson Vogel, et al.
Journal of the National Cancer Institute|January 19, 2006
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam, Jane J Kim, William F Lawrence, et al.
Evidence Report/Technology Assessment|September 4, 2007
Genomic tests for ovarian cancer detection and managementEvan R Myers, Laura J Havrilesky, Shalini L Kulasingam, et al.
Evidence Report/Technology Assessment|September 15, 2007
Management of adnexal massEvan R Myers, Lori A Bastian, Laura J Havrilesky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysisShalini L Kulasingam, Gregory P Samsa, Deborah A Zarin, et al.
Journal of Women'S Health (2002)|July 3, 2019
Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young WomenMolly A Feder, Shalini L Kulasingam, Nancy B Kiviat, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
JAMA|October 9, 2002
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referralShalini L Kulasingam, James P Hughes, Nancy B Kiviat, et al.
American Journal of Obstetrics and Gynecology|March 4, 2008
Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United StatesJanet G Baseman, Shalini L Kulasingam, Tiffany G Harris, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samplesAkhila Balasubramanian, Shalini L Kulasingam, Atar Baer, et al.
Obstetrics and Gynecology|February 2, 2006
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap testsShalini L Kulasingam, Evan R Myers, Herschel W Lawson, et al.
American Journal of Obstetrics and Gynecology|July 4, 2014
Adherence to the 2012 national cervical cancer screening guidelines: a pilot studyDeanna G K Teoh, Amity E Marriott, Rachel Isaksson Vogel, et al.
Journal of the National Cancer Institute|January 19, 2006
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam, Jane J Kim, William F Lawrence, et al.
Evidence Report/Technology Assessment|September 4, 2007
Genomic tests for ovarian cancer detection and managementEvan R Myers, Laura J Havrilesky, Shalini L Kulasingam, et al.
Evidence Report/Technology Assessment|September 15, 2007
Management of adnexal massEvan R Myers, Lori A Bastian, Laura J Havrilesky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysisShalini L Kulasingam, Gregory P Samsa, Deborah A Zarin, et al.
Journal of Women'S Health (2002)|July 3, 2019
Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young WomenMolly A Feder, Shalini L Kulasingam, Nancy B Kiviat, et al.
Pageof 4